Sweden
· Delayed Price · Currency is SEK OrganoClick AB Statistics
Total Valuation
OrganoClick AB has a market cap or net worth of SEK 288.47 million. The enterprise value is 337.15 million.
| Market Cap | 288.47M |
| Enterprise Value | 337.15M |
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OrganoClick AB has 98.12 million shares outstanding.
| Shares Outstanding | 98.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 23.09% |
| Owned by Institutions (%) | 21.60% |
| Float | 63.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.08 |
| PB Ratio | 7.04 |
| P/FCF Ratio | 48.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 231.24, with an EV/FCF ratio of 57.15.
| EV / Earnings | -19.76 |
| EV / Sales | 2.44 |
| EV / EBITDA | 231.24 |
| EV / EBIT | n/a |
| EV / FCF | 57.15 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 108.05.
| Current Ratio | 0.80 |
| Quick Ratio | 0.40 |
| Debt / Equity | 108.05 |
| Debt / EBITDA | 37.52 |
| Debt / FCF | 9.27 |
| Interest Coverage | -2.05 |
Financial Efficiency
Return on equity (ROE) is -25.87% and return on invested capital (ROIC) is -6.92%.
| Return on Equity (ROE) | -25.87% |
| Return on Assets (ROA) | -4.51% |
| Return on Capital (ROIC) | -6.92% |
| Revenue Per Employee | 3.46M |
| Profits Per Employee | -426,550 |
| Employee Count | 46 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 2.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.50% in the last 52 weeks. The beta is 1.07, so OrganoClick AB's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | -26.50% |
| 50-Day Moving Average | 3.50 |
| 200-Day Moving Average | 3.28 |
| Relative Strength Index (RSI) | 34.14 |
| Average Volume (20 Days) | 32,788 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OrganoClick AB had revenue of SEK 138.28 million and -17.06 million in losses. Loss per share was -0.17.
| Revenue | 138.28M |
| Gross Profit | 35.56M |
| Operating Income | -11.96M |
| Pretax Income | -14.64M |
| Net Income | -17.06M |
| EBITDA | -6.67M |
| EBIT | -11.96M |
| Loss Per Share | -0.17 |
Balance Sheet
The company has 15.70 million in cash and 54.71 million in debt, giving a net cash position of -39.01 million or -0.40 per share.
| Cash & Cash Equivalents | 15.70M |
| Total Debt | 54.71M |
| Net Cash | -39.01M |
| Net Cash Per Share | -0.40 |
| Equity (Book Value) | 50.63M |
| Book Value Per Share | 0.42 |
| Working Capital | -20.58M |
Cash Flow
In the last 12 months, operating cash flow was 8.26 million and capital expenditures -2.36 million, giving a free cash flow of 5.90 million.
| Operating Cash Flow | 8.26M |
| Capital Expenditures | -2.36M |
| Free Cash Flow | 5.90M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 25.72%, with operating and profit margins of -8.65% and -12.34%.
| Gross Margin | 25.72% |
| Operating Margin | -8.65% |
| Pretax Margin | -10.59% |
| Profit Margin | -12.34% |
| EBITDA Margin | -4.82% |
| EBIT Margin | -8.65% |
| FCF Margin | 4.27% |
Dividends & Yields
OrganoClick AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -5.92% |
| FCF Yield | 2.04% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |